The nation of Zimbabwe has declined a major US healthcare agreement valued at $367m (272 million pounds) over five years over the United States' request for confidential data.
The decision came to light after a government memo dated December was disclosed, indicating that President Emmerson Mnangagwa deemed the arrangement was "lopsided".
A government spokesman later explained that the United States was demanding access to biological samples for research and commercial gain but was not willing to guarantee the resulting advantages from any future treatments.
"We must now begin the difficult and regrettable task of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for continued talks to secure a deal suitable to all parties so the nation's vital HIV treatment initiative can proceed.
Broader Context
Zimbabwe's decision comes after a comparable situation in Kenya, where a court halted a similar health funding agreement following legal challenges were filed about the safety of citizens' medical information.
Since resuming office last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the American government, but Trump stated its expenditure was "inefficient" and his government was pursuing government-to-government deals to boost transparency and accountability.
As per reports, Sixteen African countries have so far agreed to these new health pacts, representing over $18.3bn in new funding.
Specifics of the Rejected Deal
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this cooperation might have yielded immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment via US-supported initiatives," Tremont added.
However, government spokesperson Nick Mangwana said the arrangement was "unequal".
"Our nation was requested to surrender its biological resources and data for a long time, without any equivalent assurance of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"Put simply, our nation would provide the basic resources for medical research without any assurance that the end products would be accessible to our population if a future disease outbreak arise."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the global health body and its push of bilateral deals were disrupting structures previously set up via the international organization.
Mangwana cited its Pathogen Access and Benefit Sharing system created to deal with future global health emergencies.
"This system is designed to guarantee that when a country provides its information, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to develop them."
These objections regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We encourage ongoing dialogue with our US partners on how subsequent co-operation might be designed in a manner that honours the sovereignty and dignity of both nations."
Medical Community Reaction
Medical experts stated it acknowledged the government's concerns, but suggested that talks should continue given that a large portion of the nation's Aids initiatives relied on international support.
"If specific concerns arise, including those involving information security or agreement terms, these can often be addressed through detailed discussion and mutually agreed protections," it commented.
The halted deal highlights the continuing debate between accepting vital foreign assistance and safeguarding a country's data in an increasingly data-driven world.